CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

47.56  -0.05 (-0.11%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCJ. CCJ was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CCJ is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

CCJ had positive earnings in the past year.
CCJ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCJ reported negative net income in multiple years.
Each year in the past 5 years CCJ had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 2.47%, CCJ is doing worse than 69.05% of the companies in the same industry.
CCJ's Return On Equity of 3.84% is on the low side compared to the rest of the industry. CCJ is outperformed by 70.00% of its industry peers.
CCJ has a worse Return On Invested Capital (2.78%) than 77.14% of its industry peers.
Industry RankSector Rank
ROA 2.47%
ROE 3.84%
ROIC 2.78%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCJ has a Profit Margin of 9.27%. This is comparable to the rest of the industry: CCJ outperforms 40.95% of its industry peers.
In the last couple of years the Profit Margin of CCJ has grown nicely.
The Operating Margin of CCJ (12.53%) is worse than 62.38% of its industry peers.
CCJ's Operating Margin has improved in the last couple of years.
CCJ has a worse Gross Margin (22.94%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 12.53%
PM (TTM) 9.27%
GM 22.94%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

4

2. Health

2.1 Basic Checks

CCJ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CCJ has more shares outstanding
CCJ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCJ is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 5.91 indicates that CCJ is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.91, CCJ belongs to the top of the industry, outperforming 89.52% of the companies in the same industry.
The Debt to FCF ratio of CCJ is 4.15, which is a neutral value as it means it would take CCJ, 4.15 years of fcf income to pay off all of its debts.
CCJ has a better Debt to FCF ratio (4.15) than 66.19% of its industry peers.
CCJ has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.17, CCJ is doing good in the industry, outperforming 73.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 4.15
Altman-Z 5.91
ROIC/WACC0.36
WACC7.75%

2.3 Liquidity

CCJ has a Current Ratio of 1.42. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
CCJ has a Current ratio (1.42) which is in line with its industry peers.
CCJ has a Quick Ratio of 1.42. This is a bad value and indicates that CCJ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.69, CCJ is doing worse than 71.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 0.69

6

3. Growth

3.1 Past

CCJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.04%, which is quite good.
Measured over the past 5 years, CCJ shows a small growth in Earnings Per Share. The EPS has been growing by 7.91% on average per year.
CCJ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.50%.
Measured over the past years, CCJ shows a small growth in Revenue. The Revenue has been growing by 4.35% on average per year.
EPS 1Y (TTM)14.04%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-51.85%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%-7.71%

3.2 Future

Based on estimates for the next years, CCJ will show a very strong growth in Earnings Per Share. The EPS will grow by 28.74% on average per year.
The Revenue is expected to grow by 5.44% on average over the next years.
EPS Next Y20.66%
EPS Next 2Y51.66%
EPS Next 3Y44.21%
EPS Next 5Y28.74%
Revenue Next Year20.49%
Revenue Next 2Y11.52%
Revenue Next 3Y9.73%
Revenue Next 5Y5.44%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 101.19, the valuation of CCJ can be described as expensive.
Based on the Price/Earnings ratio, CCJ is valued a bit more expensive than 77.14% of the companies in the same industry.
CCJ's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.08.
CCJ is valuated quite expensively with a Price/Forward Earnings ratio of 35.99.
Based on the Price/Forward Earnings ratio, CCJ is valued a bit more expensive than 73.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCJ to the average of the S&P500 Index (20.74), we can say CCJ is valued expensively.
Industry RankSector Rank
PE 101.19
Fwd PE 35.99

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued a bit more expensive than 78.57% of the companies in the same industry.
CCJ's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CCJ is more expensive than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 77.04
EV/EBITDA 58.86

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCJ does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CCJ's earnings are expected to grow with 44.21% in the coming years.
PEG (NY)4.9
PEG (5Y)12.8
EPS Next 2Y51.66%
EPS Next 3Y44.21%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.19%, CCJ is not a good candidate for dividend investing.
CCJ's Dividend Yield is slightly below the industry average, which is at 5.88.
With a Dividend Yield of 0.19, CCJ pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.19%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has been paying a dividend for at least 10 years, so it has a reliable track record.
As CCJ did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-7.75%
Div Incr Years0
Div Non Decr Years5

5.3 Sustainability

22.18% of the earnings are spent on dividend by CCJ. This is a low number and sustainable payout ratio.
DP22.18%
EPS Next 2Y51.66%
EPS Next 3Y44.21%

CAMECO CORP

NYSE:CCJ (7/23/2024, 1:50:48 PM)

47.56

-0.05 (-0.11%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap20.70B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.19%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 101.19
Fwd PE 35.99
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.9
PEG (5Y)12.8
Profitability
Industry RankSector Rank
ROA 2.47%
ROE 3.84%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.53%
PM (TTM) 9.27%
GM 22.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.42
Quick Ratio 0.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)14.04%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y20.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)17.5%
Revenue growth 3Y12.86%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y